Caspofungin 50 mg/70 mg - under development

Caspofungin 50 mg/70 mg - under development
Product Description

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes caspofungin 50 mg/70 mg - under development. It belongs to antifungal finish formulations products category. Contact us for more information.

Read more Show less

BDR PHARMACEUTICALS INTERNATIONAL PVT.

  • IN
  • 2015
    On CPHI since
  • 1000 - 4999
    Employees
Company types
Pharmaceutical company
View company profile
Categories
more categories Show less
Specifications
  • Selling Points
    International Approvals/Standards
  • Supplied from
    India
More specifications Fewer specifications

BDR PHARMACEUTICALS INTERNATIONAL PVT.

  • IN
  • 2015
    On CPHI since
  • 1000 - 4999
    Employees
Company types
Pharmaceutical company
View company profile

More Products from BDR PHARMACEUTICALS INTERNATIONAL PVT. (99)

  • Calcipotriol

    Product Calcipotriol

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes calcipotriol. It belongs to antiparathyroid & antipsoriatic apis category. Contact us for more information.
  • Calcitriol

    Product Calcitriol

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes calcitriol. It belongs to antiosteoporosis apis category. Contact us for more information.
  • Capacitabine

    Product Capacitabine

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes capacitabine. It belongs to antineoplastic apis category. Contact us for more information.
  • Capacitabine tablets 500 mg

    Product Capacitabine tablets 500 mg

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes capacitabine tablets 500 mg. It belongs toanticancer ( oral / injection) finish formulations products category. Contact us for more information.
  • Carboplatin injection 150 mg/ 450 mg

    Product Carboplatin injection 150 mg/ 450 mg

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes carboplatin injection 150 mg/ 450 mg. It belongs toanticancer ( oral / injection) finish formulations products category. Contact us for more information.
  • Caspofungin

    Product Caspofungin

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes caspofungin. It belongs to antifungal apis category. Contact us for more information.
  • Caspofungin acetate

    Product Caspofungin acetate

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes caspofungin acetate. It belongs to antifungal apis category. Contact us for more information.
  • Cefdinir

    Product Cefdinir

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes cefdinir. It belongs to cephalosporins apis products category. Contact us for more information.
  • Cefditoren pivoxil

    Product Cefditoren pivoxil

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes cefditoren pivoxil. It belongs to cephalosporins apis products category. Contact us for more information.
  • Cefepime + sulbactam for injection (1000 + 500) / (500 + 250) mg

    Product Cefepime + sulbactam for injection (1000 + 500) / (500 + 250) mg

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes cefepime + sulbactam for injection (1000 + 500) / (500 + 250) mg. It belobgs to antibacterial cephalosporins finish formulations products category. Contact us for more information.
  • Cefepime + tazobactum for injection (1000 + 125) / (500 + 62.5) / (250 + 31.25) mg

    Product Cefepime + tazobactum for injection (1000 + 125) / (500 + 62.5) / (250 + 31.25) mg

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes cefepime + tazobactum for injection (1000 + 125) / (500 + 62.5) / (250 + 31.25) mg. It belobgs to antibacterial cephalosporins finish formulations products category. Contact us for m...
  • Cefepime +amikacin injection (500 + 125) / (1000 + 250) / (2000 + 500) mg

    Product Cefepime +amikacin injection (500 + 125) / (1000 + 250) / (2000 + 500) mg

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes cefepime +amikacin injection (500 + 125) / (1000 + 250) / (2000 + 500) mg. It belobgs to antibacterial cephalosporins finish formulations products category. Contact us for more infor...
show all 99 other products

BDR PHARMACEUTICALS INTERNATIONAL PVT. resources (1)